Related Experiment Video
Updated: Apr 17, 2026
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Oncogenic mutation profiling in new lung cancer and mesothelioma cell lines
David Cl Lam1, Susan Y Luo1, Wen Deng2
1Department of Medicine, University of Hong Kong, Hong Kong SAR, People's Republic of China.
Background:
Thoracic tumor, especially lung cancer, ranks as the top cancer mortality in most parts of the world. Lung adenocarcinoma is the predominant subtype and there is increasing knowledge on therapeutic molecular targets, namely EGFR, ALK, KRAS, and ROS1, among lung cancers. Lung cancer cell lines established with known clinical characteristics and molecular profiling of oncogenic targets like ALK or KRAS could be useful tools for understanding the biology of known molecular targets as well as for drug testing and screening.
Materials And Methods:
Five new cancer cell lines were established from pleural fluid or biopsy tissues obtained from Chinese patients with primary lung adenocarcinomas or malignant pleural mesothelioma. They were characterized by immunohistochemistry, growth kinetics, tests for tumorigenicity, EGFR and KRAS gene mutations, ALK gene rearrangement and OncoSeq mutation profiling.
Results:
These newly established lung adenocarcinoma and mesothelioma cell lines were maintained for over 100 passages and demonstrated morphological and immunohistochemical features as well as growth kinetics of tumor cell lines. One of these new cell lines bears EML4-ALK rearrangement variant 2, two lung cancer cell lines bear different KRAS mutations at codon 12, and known single nucleotide polymorphism variants were identified in these cell lines.
Discussion:
Four new lung adenocarcinoma and one mesothelioma cell lines were established from patients with different clinical characteristics and oncogenic mutation profiles. These characterized cell lines and their mutation profiles will provide resources for exploration of lung cancer and mesothelioma biology with regard to the presence of known oncogenic mutations.
Insights
Researchers established five new lung cancer cell lines from Chinese patients. These cell lines, characterized by specific gene mutations like EML4-ALK and KRAS, offer valuable tools for studying lung adenocarcinoma and mesothelioma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Lung cancer is a leading cause of cancer mortality worldwide.
- Lung adenocarcinoma is the most common subtype, with known therapeutic molecular targets such as EGFR, ALK, KRAS, and ROS1.
- Established lung cancer cell lines with characterized molecular profiles are crucial for biological studies and drug development.
Purpose of the Study:
- To establish and characterize new cancer cell lines from Chinese patients with lung adenocarcinoma and malignant pleural mesothelioma.
- To provide valuable tools for understanding the biology of known molecular targets in lung cancer.
- To facilitate drug testing and screening for thoracic tumors.
Main Methods:
- Five new cell lines were generated from pleural fluid or biopsy tissues of Chinese patients.
- Characterization included immunohistochemistry, growth kinetics, tumorigenicity tests, and analysis of EGFR/KRAS mutations and ALK rearrangements.
- OncoSeq mutation profiling was performed on the established cell lines.
Main Results:
- The five cell lines (four lung adenocarcinoma, one mesothelioma) were maintained for over 100 passages.
- One cell line exhibited EML4-ALK rearrangement (variant 2).
- Two lung cancer cell lines harbored KRAS mutations at codon 12; single nucleotide polymorphism variants were also identified.
Conclusions:
- Four new lung adenocarcinoma and one mesothelioma cell lines were successfully established and characterized.
- These cell lines possess distinct clinical characteristics and oncogenic mutation profiles.
- The characterized cell lines and their mutation data serve as resources for investigating lung cancer and mesothelioma biology, particularly concerning known oncogenic mutations.
More Related Videos
Related Concept Videos
02:18Cancer
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
02:21Cancers Originate from Somatic Mutations in a Single Cell
02:21Cancers Originate from Somatic Mutations in a Single Cell